[Pseudosarcomatous osteolysis in a Paget's disease patient treated with disodium etidronate (EHDP)].
D001859:Bone Neoplasms / Q000175:diagnosis*; D001862:Bone Resorption / Q000139:chemically induced*; D002116:Calcitonin / Q000627:therapeutic use; D003937:Diagnosis, Differential; D012968:Etidronic Acid / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D010014:Osteolysis / Q000139:chemically induced*; D011859:Radiography; D011884:Radius / Q000000981:diagnostic imaging / Q000187:drug effects*; D012509:Sarcoma / Q000175:diagnosis*
D002116:Calcitonin; D012968:Etidronic Acid
Ostéolyse pseudo-sarcomateuse chez un pagétique traité par l'etidronate disodique (EHDP).